CytomX Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
CTMX
CUSIP
23284F105
Type
Equity
Class
COM
Num filers
85
Total reported value, excl. options
$303M
Manager Report Date Value ($000) Shares Option Type